Mereo BioPharma Group (MREO) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MREO Stock Alerts $3.03 -0.24 (-7.34%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEuropean Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Tradingmsn.com - May 1 at 12:44 PMAnalysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Mereo Biopharma Group Plc (MREO) and Arcus Biosciences (RCUS)markets.businessinsider.com - May 1 at 12:44 PMStrong Buy Rating for Mereo Biopharma on Setrusumab’s Promising Phase 3 Progress and Financial Outlookmarkets.businessinsider.com - May 1 at 12:44 PMabrdn plc Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)marketbeat.com - April 29 at 5:16 AMMereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 3 at 7:30 AMMereo BioPharma Group (NASDAQ:MREO) Earns Overweight Rating from Cantor Fitzgeraldmarketbeat.com - March 28 at 11:51 AMMereo BioPharma Group (NASDAQ:MREO) Price Target Raised to $6.00marketbeat.com - March 28 at 8:28 AMMereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 27 at 4:01 PMMereo BioPharma Group (NASDAQ:MREO) Given "Overweight" Rating at Cantor Fitzgeraldmarketbeat.com - March 22 at 2:58 PMMREO Apr 2024 3.500 putfinance.yahoo.com - March 16 at 8:29 PMMREO Aug 2024 5.500 callca.finance.yahoo.com - March 16 at 5:27 AMMREO Apr 2024 1.500 callfinance.yahoo.com - March 16 at 5:27 AMMREO Apr 2024 3.000 putfinance.yahoo.com - March 16 at 5:27 AMMereo BioPharma Group plc (NASDAQ:MREO) Short Interest Down 19.8% in Februarymarketbeat.com - March 14 at 6:54 AMVoyager Therapeutics gets new chief medical officerseekingalpha.com - March 13 at 12:43 PMAdage Capital Partners GP L.L.C. Purchases Shares of 800,000 Mereo BioPharma Group plc (NASDAQ:MREO)marketbeat.com - March 12 at 5:54 AMMereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 5 at 7:30 AM683 Capital Management LLC Purchases 600,000 Shares of Mereo BioPharma Group plc (NASDAQ:MREO)marketbeat.com - March 1 at 10:35 AMMereo BioPharma Group plc (MREO)finance.yahoo.com - February 23 at 3:00 AMMereo BioPharma Group plc (NASDAQ:MREO) Shares Acquired by Tejara Capital Ltdmarketbeat.com - February 16 at 12:21 PMFormidable Asset Management LLC Acquires New Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)marketbeat.com - February 14 at 9:39 AMMereo BioPharma Group plc to Post FY2023 Earnings of ($0.04) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:MREO)marketbeat.com - February 9 at 6:27 AMMereo BioPharma Group (NASDAQ:MREO) Reaches New 12-Month High at $4.36marketbeat.com - February 5 at 11:32 AMAM Best Assigns Preliminary Credit Assessment to Mereo Insurance Limitedfinance.yahoo.com - January 31 at 1:49 PMAnalysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)markets.businessinsider.com - January 15 at 8:04 AMMereo BioPharma Group plc (NASDAQ:MREO) Short Interest Updatemarketbeat.com - December 29 at 5:10 AMMereo BioPharma Group Stock (NASDAQ:MREO) Dividends: History, Yield and Datesbenzinga.com - December 20 at 8:54 PMHedge Funds Say These Penny Stocks Are Poised to Explodefinance.yahoo.com - December 19 at 2:11 PMUltragenyx (RARE) Q3 Earnings and Revenues Miss Estimatesfinance.yahoo.com - November 3 at 2:45 PMMereo BioPharma Group plc: Mereo BioPharma Reports on Recent Program Developments and Provides Financial Updatefinanznachrichten.de - October 25 at 8:14 AMAnalysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO)markets.businessinsider.com - October 25 at 12:44 AMWhy Is Mereo BioPharma Stock Trading Higher Today?benzinga.com - October 16 at 2:50 PMUltragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)finance.yahoo.com - October 14 at 7:34 PMMREO Oct 2023 2.500 putfinance.yahoo.com - September 27 at 3:09 PMCantor Fitzgerald Reiterates Mereo Biopharma Group Plc - ADR (MREO) Overweight Recommendationmsn.com - September 9 at 11:46 AMMereo BioPharma Group (NASDAQ:MREO) Issues Earnings Results, Hits Estimatesmarketbeat.com - September 8 at 7:57 AMMereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Updatefinance.yahoo.com - September 7 at 10:02 AMMereo BioPharma Group Plc (NASDAQ: MREO)fool.com - August 19 at 9:14 AMBAKER BROS. ADVISORS LP Acquires Significant Stake in Mereo BioPharma Group PLCfinance.yahoo.com - August 11 at 3:30 PMMereo Biopharma Group Plc - ADR (MREO) Price Target Decreased by 7.69% to 4.08msn.com - July 6 at 10:42 PM683 Capital Management LLC Makes New Investment in Mereo BioPharma Group plc (NASDAQ:MREO)marketbeat.com - June 13 at 5:37 AMNeedham Reiterates Mereo Biopharma Group Plc - ADR (MREO) Prior Recommendationmsn.com - June 7 at 2:13 AMNeedham Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)markets.businessinsider.com - May 27 at 12:15 AMPhase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conferencefinance.yahoo.com - May 23 at 7:41 PMNeedham Reiterates Mereo Biopharma Group Plc - ADR (MREO) Buy Recommendationmsn.com - April 21 at 7:26 PMNeedham Reaffirms Their Buy Rating on Mereo Biopharma Group Plc (MREO)markets.businessinsider.com - April 21 at 2:26 PMWhat Makes MEREO BIOPHARMA (MREO) a Strong Momentum Stock: Buy Now?finance.yahoo.com - April 21 at 2:26 PMMereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conferencefinance.yahoo.com - April 13 at 11:48 AMMereo BioPharma Group plc: Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlightsfinanznachrichten.de - March 29 at 10:26 AMMereo BioPharma Provides Regulatory Updates on Alvelestat for the Treatment of Alpha-1-Antitrypsin Deficiency-Associated Lung Diseasefinance.yahoo.com - March 21 at 9:27 AM Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide MREO Media Mentions By Week MREO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.000.52▲Average Medical News Sentiment MREO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼10▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ERAS News Today RANI News Today TERN News Today HROW News Today NATR News Today ADCT News Today AMRN News Today ANRO News Today PGEN News Today ATAI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.